Cases & Deals

Nanjing Legend Biotech establishes global patent portfolio for CAR-T therapeutics

Clients Nanjing Legend Biotech Co., Ltd et al

Jones Day represents Nanjing Legend Biotech Co., Ltd et al in the development and prosecution of global patent portfolios related to chimeric antigen receptor T cell (CAR-T) and other cellular therapeutics, including certain clinical trial candidates.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.